Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III)

NCT01257360 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Panitumumab
RADIATION: Radiation of the pelvis

Sponsor

WiSP Wissenschaftlicher Service Pharma GmbH

Collaborators

[object Object]